Actuate Therapeutics ACTU Insider Ownership

NASDAQ ACTU

$0.32 +0.01 (+3.22%)

As of: Nov 10, 2026 · 12:17 PM EST

Insider Holdings by Owner

1.94Mn Shares

Todd S Thomson904.80K46.7%

Daniel M Schmitt442.56K22.9%

Aaron G.L. Fletcher196.43K10.1%

Leslie W. Kreis196.43K10.1%

Equity Cof, Lp Bios196.43K10.1%

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

57.49%

▲+0.631% pp QoQ

Shares Held by Insiders

13.81Mn

filed for Sep 2026

▲+1.11% QoQ

Shares Outstanding

24.01Mn

24,013,577 shares

Direct Holdings

301.72K

Indirect: 13.50Mn

Net Open-Market Trades

no open-market trades in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Open-Market Insider Trades

Bought Sold

Latest quarter —

Net over range —

Net-buying quarters —

Insider Ownership Summary

Updated Nov 4, 2026

Over the past 12 months, Actuate Therapeutics insiders bought $50,000 of stock on the open market (140.84K shares) and sold $1.62 million (280K shares).

Among Actuate Therapeutics insiders, Daniel M. Schmitt (President, CEO and Director) led open-market buying over the past 12 months with $50,000 of purchases (140.84K shares); the latest was on October 28, 2026.
On the selling side, Todd S. Thomson (Director and 10% owner) sold the most Actuate Therapeutics stock on the open market over the past 12 months, $1.62 million (280K shares), most recently on January 5, 2026.
Away from the open market, ACTU insiders acquired 544.11K shares through option exercises and conversions and gave up 242.4K shares to cover taxes or exercise prices over the last 12 months.
Business Quant data shows Actuate Therapeutics insiders holding 13.95Mn shares in total in their latest Form 4 filings, or 58.08% of the 24.01Mn shares outstanding; that total is up 2.14% from 13.65Mn shares at the end of Q2 2026 and up 10.69% from 12.6Mn shares at the end of Q3 2025.
Indirect holdings, through trusts, partnerships, family members and other entities, make up 96.83% (13.5Mn shares) of Actuate Therapeutics' insider total, with the other 3.17% (442.56K shares) held directly.
Business Quant counts 3 insiders with holdings in Actuate Therapeutics stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
Actuate Therapeutics' top three insider holders by shares held are Bios Equity Cof, LP (Director and 10% owner, 9.97Mn shares), Todd S. Thomson (Director and 10% owner, 3.54Mn shares) and Daniel M. Schmitt (President, CEO and Director, 442.56K shares).
The holding of Bios Equity Cof, LP makes up 71.45% of all shares held by Actuate Therapeutics insiders.
In the past year, 12 insiders of Actuate Therapeutics submitted 17 Form 4 filings reporting trades, awards or other transactions.
Insider figures for ACTU include Form 4 filings through November 2, 2026.

Form 4 Holdings

Insiders Holding ACTU

Insiders 5

Shares held 1.94Mn

Of outstanding 8.06%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Todd S Thomson	Director, TenPercentOwner	0	904,795	904,795	46.7%	07 Jan, 2026
2	Daniel M Schmitt	President, Ceo And Director	442,560	0	442,560	22.9%	29 Oct, 2026
3	Aaron G.L. Fletcher	Director, TenPercentOwner	0	196,428	196,428	10.1%	30 Jun, 2025
4	Leslie W. Kreis	Director, TenPercentOwner	0	196,428	196,428	10.1%	30 Jun, 2025
5	Equity Cof, Lp Bios	Director, TenPercentOwner	0	196,428	196,428	10.1%	30 Jun, 2025

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

272 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
28 Oct, 2026	Todd S Thomson	Director	Acquired A	269,017	—	—	269,017	Indirect
28 Oct, 2026	Todd S Thomson	Director	Acquired A	259,572	—	—	259,572	Indirect
28 Oct, 2026	Todd S Thomson	Director	Acquired A	75,738	—	—	75,738	Indirect
28 Oct, 2026	Todd S Thomson	Director	Acquired A	95,673	—	—	95,673	Indirect
28 Oct, 2026	Fund I, Lp Bios	Director, TenPercentOwner	Acquired A	64,995	$0.00	$0	64,995	Indirect
28 Oct, 2026	Fund Iii, Lp Bios	Director, TenPercentOwner	Acquired A	64,995	$0.00	$0	64,995	Indirect
28 Oct, 2026	Fund Iii, Lp Bios	Director, TenPercentOwner	Acquired A	87,743	$0.00	$0	87,743	Indirect
28 Oct, 2026	Fund I, Lp Bios	Director, TenPercentOwner	Acquired A	87,743	$0.00	$0	87,743	Indirect
28 Oct, 2026	Fund I, Lp Bios	Director, TenPercentOwner	Acquired A	682,885	$0.00	$0	682,885	Indirect
28 Oct, 2026	Fund Iii, Lp Bios	Director, TenPercentOwner	Acquired A	682,885	$0.00	$0	682,885	Indirect
28 Oct, 2026	Fund Iii, Lp Bios	Director, TenPercentOwner	Acquired A	194,984	$0.00	$0	194,984	Indirect
28 Oct, 2026	Fund I, Lp Bios	Director, TenPercentOwner	Acquired A	194,984	$0.00	$0	194,984	Indirect
28 Oct, 2026	Fund Iii, Lp Bios	Director, TenPercentOwner	Acquired A	368,304	$0.00	$0	368,304	Indirect
28 Oct, 2026	Fund I, Lp Bios	Director, TenPercentOwner	Acquired A	368,304	$0.00	$0	368,304	Indirect
28 Oct, 2026	Fund Iii, Lp Bios	Director, TenPercentOwner	Acquired A	47,972	$0.00	$0	47,972	Indirect
28 Oct, 2026	Fund I, Lp Bios	Director, TenPercentOwner	Acquired A	47,972	$0.00	$0	47,972	Indirect
28 Oct, 2026	Fund Iii, Lp Bios	Director, TenPercentOwner	Acquired A	82,018	$0.00	$0	82,018	Indirect
28 Oct, 2026	Fund I, Lp Bios	Director, TenPercentOwner	Acquired A	82,018	$0.00	$0	82,018	Indirect
28 Oct, 2026	Fund I, Lp Bios	Director, TenPercentOwner	Acquired A	36,056	$0.00	$0	36,056	Indirect
28 Oct, 2026	Fund Iii, Lp Bios	Director, TenPercentOwner	Acquired A	36,056	$0.00	$0	36,056	Indirect

Showing 1 to 20 of 272 transactions